Elevess Elevates Artes Medical Revenues
Artes Medical, maker of the longer-lasting injectable filler ArteFill and distributor of the newest filler on the block Elevess, reported an increase of $1.1 million, or 85%, over product sales of $1.2 million for the same quarter in 2007.
Seattle doctor Stacy J. Davies, MD, an early adopter of Elevess, says she prefers Elevess for plumping lips and filling in those "lipstick lines" or "smoker's lines" around the mouth.
In a press release Christopher J. Reinhard, Executive Chairman of Artes Medical, Inc. said "While the challenging economic times have adversely impacted the aesthetics sector, we have advanced product revenues over the prior year period while launching a new product, Elevess. The summer is often considered a slow quarter for sales in our industry.
"However, we and all of our competitors have experienced the negative effects of the current recession and credit crisis and the weather conditions in the Gulf Coast region, especially during the month of September.
"As a result, based on the deteriorating economic outlook, unfavorable market and poor financial metrics of the medical aesthetics industry, the Company is not in a position at this time to estimate projected revenues for the fourth quarter of the year. We are therefore suspending our guidance for the remainder of the 2008 calendar year."
Kristin Meyer for Real Beauty News
Return to RealSelf blog
Write a comment